Biomarin Pharmaceutical (BMRN) Asset Utilization Ratio (2010 - 2026)

Biomarin Pharmaceutical (BMRN) has 17 years of Asset Utilization Ratio data on file, last reported at 0.4 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 4.01% year-over-year to 0.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.4 (down 4.01% YoY) and the FY2025 annual result came in at 0.44, up 7.05% from the prior year.
• Asset Utilization Ratio eased to 0.4 in Q1 2026, from 0.42 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q4 2025 to a low of 0.31 in Q1 2022.
• A 5-year average of 0.37 and a median of 0.36 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio declined 4.38% — and 2024, when it gained 15.92%.
• Tracing BMRN's Asset Utilization Ratio over 5 years: stood at 0.33 in 2022, then gained by 7.27% to 0.36 in 2023, then rose by 15.92% to 0.41 in 2024, then grew by 2.71% to 0.42 in 2025, then retreated by 5.42% to 0.4 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.4 (Q1 2026), 0.42 (Q4 2025), and 0.41 (Q3 2025), per Business Quant data.